Methyl 3-bromo-1-methyl-1H-pyrrole-2-carboxylate, 98%, 250mg

2-CHLORO-N-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE, 95%, 1g

N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine>98.0%(HPLC)(N)200mg

1-([(TERT-BUTOXY)CARBONYL]AMINO)-2-METHYLCYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 100mg

3-(Thiophene-2-sulfonamido)propanoic acid, 97%, 100mg

2-Bromo-6-methyl-4-trifluoromethylpyridine, 95.0%, 10g

3-Bromo-5-methyl-1,2,4-oxadiazole, 95.0%, 5g

6-Phenoxynicotinonitrile, 95.0%, 5g

4-Benzyloxy-3,3-dimethylbut-1-yne, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(difluoro(phosphono)methyl)phenyl)propanoic acid, 98%, 1g

GC capillary column ROTI®Cap-1701, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

3,5-Dibromo-1H-pyrazole-4-carbonitrile, 97%, 250mg

2-(3,5-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g